May 30, 2023 / 12:00PM GMT
Operator
(technical difficulty) panel discussion. (Operator Instructions) As a reminder, this call is being recorded, and a replay will be made available on the SELLAS website following the conclusion of the event.
I'd now like to turn the call over to your host, Dr. Angelos Stergiou, Founder, President and Chief Executive Officer of SELLAS Life Sciences Group. Please go ahead, Angelos.
Angelos M. Stergiou - SELLAS Life Sciences Group, Inc. - Founder, President, CEO & Director
Thank you, and good morning, everyone, and welcome to SELLAS' GFH009 expert panel call. First, thank you for your participation and support in joining us today. We're very excited to take this time to focus on some important developments regarding the GFH009 program, particularly around the upcoming Phase IIa relapsed/refractory AML study and very pleased with FDA's comments and inputs to our trial design.
It is my pleasure to also be joined by doctors Kadia, Zeidner and Jamy as well as our Senior Vice President of Clinical Development, Dr. Dragan Cicic, and our Senior Vice
Sellas Life Sciences Group Inc Expert Panel Discussion Transcript
May 30, 2023
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers